© 1999 by Biometrika Trust
Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
A1 M. D. Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA E-mail: yushen@odin.mdacc.tmc.edu A Department of Biostatistics, Harvard School of Public Health, and Dana Farber Cancer Institute, Boston, MA 02115, USA zelen@jimmy.harvard.edu
This paper develops methods for estimating the parameters associated with early detection programmes. Disease is considered to have three states: a disease-free state or a state in which the disease cannot be detected, a preclinical state and a clinical state. The natural history of the disease is assumed to be progressive. The parameters to be estimated are the sensitivity of one or two disease detection modalities and the characteristics of the preclinical sojourn time distribution under both the stable disease and nonstable disease models. The stable-disease model assumes that the incidence of prevalence of a disease is independent of age or chronological time, while the nonstable disease model allows quantities to depend on time. With the nonstable disease model, the relevant parameters can be jointly estimated by a two-step iteration procedure from the likelihood function. For the stable disease model, the sensitivity and the parameters of the sojourn time distribution of the preclinical state can be obtained directly from a conditional likelihood function. Applications are made to recent clinical trials for the early detection of breast cancer.
Key Words: Conditional likelihood; Multiple screening examination; Nonstable disease model; Sensitivity; Sojourn time; Stable disease model
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. D Mahnken, W. Chan, D. H Freeman Jr, and J. L Freeman Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach Statistical Methods in Medical Research, December 1, 2008; 17(6): 643 - 663. [Abstract] [PDF] |
||||
![]() |
Y. Shen and M. Zelen Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution Biostat., October 1, 2005; 6(4): 604 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen and G. Parmigiani A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast Examinations Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 529 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
L G Hanin and A Y Yakovlev Multivariate distributions of clinical covariates at the time of cancer detection Statistical Methods in Medical Research, December 1, 2004; 13(6): 457 - 489. [Abstract] [PDF] |
||||
![]() |
P. Hu and M. Zelen Planning of randomized early detection trials Statistical Methods in Medical Research, December 1, 2004; 13(6): 491 - 506. [Abstract] [PDF] |
||||
![]() |
Y. Shen and M. Zelen Screening Sensitivity and Sojourn Time From Breast Cancer Early Detection Clinical Trials: Mammograms and Physical Examinations J. Clin. Oncol., August 1, 2001; 19(15): 3490 - 3499. [Abstract] [Full Text] [PDF] |
||||



